The latest reporting and analysis on breakthroughs in Parkinson's research and issues that matter most to you.
July 20, 2017
MJFF is partnering to send LRRK2 protein to the International Space Station to grow larger LRRK2 crystals, which can help develop therapies. Michael J. Fox shares a special message on this project.
July 17, 2017
Scientists are testing drugs used for high blood pressure and diabetes for their effects on Parkinson's disease. MJFF CEO Todd Sherer, PhD, discusses this tactic of drug repurposing.
July 17, 2017
Matt Keswick was diagnosed with PD at the age of 39. Once he decided to go public with his diagnosis, Matt got involved with Team Fox where he found a renewed sense of optimism.
July 14, 2017
Guest blogger B.J. Bement talks about the importance of advocating for health care and making your voice heard.
July 12, 2017
From hosting a craft beer party to running marathons, Rose and Chris Babcock are Team Fox members in more ways than one.
July 11, 2017
In the latest in our "Getting to a Cure: Science behind the Search" series, we cover the proposed connection between sticky protein alpha-synuclein and the immune system.
July 10, 2017
Five projects targeting alpha-synuclein are in clinical trials with more preparing for testing.
July 04, 2017
Jimmy Choi is a Team Fox MVP who was diagnosed with Parkinson's disease at 27. Watch as he takes on his latest challenge -- the American Ninja Warrior obstacle course.
June 29, 2017
MJFF scientist speaks to "Nature Reviews Drug Discovery" about alpha-synuclein research progress in Parkinson's disease.
June 27, 2017
In the latest Ask the MD video, Dr. Dolhun talks about repurposed therapies for Parkinson's disease and what patients and families should know.